Can Stress Management Improve Vaccine Immune Response
Chronic stress can impair immune function, including immune response to vaccines. This has
important implications for cancer control and prevention because tumor vaccines are emerging
as tools for cancer treatment and prevention, and the cohort that would benefit from the
vaccines is likely to be stressed. Women at elevated risk for breast cancer experience
significant levels of distress that have been associated with immune function decrements.
Interventions to treat distress-related immune decrements among these women are needed
because these women will be among the first candidates for breast cancer vaccines. In
theory, stress-management interventions should improve immune function and response to
vaccines, but the findings to date are mixed, in part because most intervention studies have
been done with medical patients who by nature have immune confounds. Thus, it is unknown how
stress management interventions affect immune function in stressed but otherwise healthy
people, such as women at elevated risk for breast cancer.
Comparison: Women will be randomly assigned to a 10-week structured, CBSM intervention or a
wait-list comparison group with delay participation in the intervention. The comparison
group will be offered the full CBSM intervention after all assessment time points have been
completed.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Independent sample t-test will be used to compare 1) antibody change scores from before to after the first and second dose of vaccine, and 2) distress change scores from before to after the intervention
length of protocol
No
Bonnie A. McGregor, PhD
Principal Investigator
Fred Hutchinson Cancer Research Center
United States: Institutional Review Board
IRB-6003
NCT00121160
September 2005
July 2010
Name | Location |
---|---|
Fred Hutchinson Cancer Research Center | Seattle, Washington 98109 |